Dr. Reddy's Laboratories Ltd.
DRREDDY
Dr. Reddy's Laboratories Ltd. Share Price
1,229.50 -16.70 (-1.34%)Dr. Reddy’s Laboratories is an Indian-origin multi-national company in the pharmaceutical sector. It is involved in the manufacturing and marketing of a wide catalogue of pharmaceuticals in the global market. The company was founded in 1984 and is headquartered in Hyderabad, India.
Business Segment
The business segments include:
- Pharmaceutical Services and Active Ingredients: primarily consists of the company’s business of manufacturing and marketing APIs and intermediates
- Global Generics: consists of the business of manufacturing and marketing prescription and OTC finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics)
Geographical Presence
Its geographical footprint covers the USA, India, Russia & CIS nations, China, Brazil, and Europe.
Fundamentals
Market Cap₹1,03,350Cr | EPS₹50.35 |
Book Value/Share₹453.97 | P/E Ratio (TTM)24.27 |
Industry P/E (TTM)43.67 | P/B Ratio3.11 |
Long Term D/E0.20 | ROE12.06% |
Dividend Yield (TTM)0.60% |
Analysis
Overview
Key stock indicators that show how well a company is doing, making it easier to understand its true value and performance.
Outperformer
Somewhat Undervalued
Good Quality
Low Price Fluctuation
Analysts are Neutral
Peer Comparison
Peer comparison lists companies from the same sector, scored and ranked based on Crisp Analysis. It helps understand how a company stands against its competitors.
Shareholding Pattern
Shareholding pattern shows how a company’s shares (ownership) are distributed among different shareholding entities like promoters, Foreign Institutional Investors (FIIs), Domestic Institutional Investors (DIIs), and retail investors, among others. Changes in the shareholding pattern can indicate the performance outlook of a stock.
FAQs on Dr. Reddy's Laboratories Ltd.
The share price of Dr. Reddy's Laboratories Ltd. is ₹1,229.50 on NSE as of 15/7/2026, 10:34:35 pm. Share prices may change frequently due to market movements.
The market capitalisation of Dr. Reddy's Laboratories Ltd. is ₹1,03,350Cr as of 15/7/2026, 10:34:35 pm
The current Price to Earnings (P/E) ratio of Dr. Reddy's Laboratories Ltd. is 24.27 as of 15/7/2026, 10:34:35 pm
The Price to Book (P/B) ratio of Dr. Reddy's Laboratories Ltd. stands at 3.12 as of 15/7/2026, 10:34:35 pm
Dr. Reddy's Laboratories Ltd. reported an ROE of 12.06% for the last reported financial year on a consolidated account basis.
As of 15/7/2026, 10:34:35 pm, Dr. Reddy's Laboratories Ltd.’s shareholding pattern is: promoters hold 26.60%, FIIs hold 21.10%, DIIs hold 29.50%, and public shareholders hold 9.30%.
The 52-week high of Dr. Reddy's Laboratories Ltd. is ₹1,249.10 and the 52-week low is ₹1,226.40 as of 15/7/2026, 10:34:35 pm.
The earnings per share (EPS) of Dr. Reddy's Laboratories Ltd. is ₹2.65 for the quarter ended Mar 2026.
The stock symbol of Dr. Reddy's Laboratories Ltd. is DRREDDY.
You can buy Dr. Reddy's Laboratories Ltd. shares by opening a demat and trading account with Share.Market and placing a buy order on NSE or BSE during market hours.
The fair value of Dr. Reddy's Laboratories Ltd. depends on factors such as earnings growth, financial performance, and overall market conditions. Investors should assess fundamentals before making investment decisions.
Earnings Per Share
Earnings per share (EPS) measures the profit earned by a company for each of its outstanding shares. Generally, the higher a company’s EPS is, the more profitable it is considered to be.
Income Statement
Also called a profit and loss statement, an income statement shows a company’s income, expenses, and how much profit or loss it has made over a specific accounting period. It provides a clear view of how well the business is running.
| Particulars (in Cr) | Mar 2026 | Q/Q Change |
|---|---|---|
| Operating Revenue | 7,546.40 | -13.79% |
| Other Income | 475.40 | +76.86% |
| Total Income | 8,021.80 | -11.09% |
| Total Expenditure | 6,906.40 | +0.59% |
| EBIDT | 857.90 | -60.21% |
| Depreciation | 557.10 | +6.93% |
| Interest | 105.70 | +11.97% |
| Tax | -21.60 | -106.11% |
| Net Profit | 220.90 | -81.74% |
Balance Sheet
A balance sheet is a financial statement that details a company’s assets, liabilities, and shareholders’ equity at a given time. It helps assess how financially strong and stable the company is.
| Particulars (in Cr) | Mar 2026 |
|---|---|
| Total Current Assets | 30,179.30 |
| Total Non-Current Assets | 27,944.10 |
| Fixed assets | 22,043.80 |
| Total Assets | 58,123.40 |
| Total Current liabilities | 16,747.40 |
| Total Non Current Liabilities | 3,145.10 |
| Total Equity Plus Liabilities | 58,123.40 |
| Total Shareholder Funds | 37,891.50 |
| Total Debt to Equity | 17.00% |
Cash Flow
Cash flow highlights the cash or cash equivalents moving in and out of a company during a particular period. It provides a clear picture of how well a company manages its cash by tracking its operating, investing and financing activities.
| Particulars (in Cr) | Mar 2026 |
|---|---|
| Cash from Operating Activity | 5,673.70 |
| Cash from Financing Activities | 829.00 |
| Cash from Investing Activities | -6,549.30 |
| Net Cash Flow | -46.60 |
Time Period: Daily
SMA/EMA (Moving Average) Analysis
Bullish Moving Averages0
Bearish Moving Averages16
5 Day
1,268.7010 Day
1,312.6020 Day
1,310.7030 Day
1,298.2050 Day
1,301.10100 Day
1,288.10150 Day
1,272.90200 Day
1,266.90Indicators
RSI (14)
37.29MACD (12, 26)
-7.02MACD Signal Line (9)
6.14MFI (14)
41.81ATR (14)
34.33ADX (14)
26.37ROC (21)
-2.29ROC (125)
0.27Pivot Analysis
Pivot analysis uses a special price point, called the pivot point, to show the overall market trend during different periods. This pivot point is the average of the previous day’s high, low, and closing prices of a specific asset.
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 1,252.40 | 1,258.60 | 1,269.20 | 1,241.80 | 1,235.60 | 1,225.00 | 1,218.80 |
Note: Support and Resistance level for the day, calculated based on price range of the previous trading day.
Volume Analysis
Volume analysis tracks how many shares were traded for a specific period. Total traded volume represents the overall number of shares traded, while combined delivery volume indicates only those shares which are delivered (transferred for ownership). Delivered shares indicate long-term investor interest.
Dr. Reddy's Laboratories Ltd.
DRREDDY
Open Price | 1,249.10 |
Prev Close | 1,246.20 |
Upper Circuit | 1,370.80 |
Lower Circuit | 1,121.60 |
Volume | 16,85,660 |
Average Traded Price | 1,232.62 |
Historical Performance
| 1 Day | NA |
| 5 Days | NA |
| 1 Month | NA |
| 3 Months | NA |
| 1 Year | NA |
| 5 Years | NA |
| 10 Years | NA |